Vista, CA, United States of America

Anthony Scozzari

This inventor holds 6 USPTO granted patents. Top assignee: Isis Pharmaceuticals, Inc.. Active years: 2000-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anthony Scozzari. Retrieved from https://idiyas.com/inventor/anthony-scozzari

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 66.7

Average Co-Inventor Count = 2.5

ph-index = 2

Forward Citations = 187(Granted Patents)


Company Filing History:


Years Active: 2000-2007

Loading Chart...
6 patents (USPTO):Explore Patents

Title: **The Innovations of Anthony Scozzari: Pioneering Oligonucleotide Synthesis**

Introduction

Anthony Scozzari, based in Vista, California, is a notable inventor recognized for his contributions to the field of biotechnology. With a total of six patents to his name, he has made significant strides in the synthesis of oligonucleotides, which play a critical role in various biological applications, including genetic research and therapeutics.

Latest Patents

Scozzari's most recent inventions include groundbreaking methodologies that enhance oligonucleotide synthesis. One patent outlines a method for manufacturing oligonucleotides using a pentavalent phosphate triester. This innovative approach involves a series of steps: starting with a 5’ blocked-nucleoside, which is then deblocked to create a 5’ OH-nucleoside. This method culminates in the coupling of the OH-nucleoside with a phosphoramidite, leading to an oligonucleotide formation. Essential to the process is the incorporation of specific solvent washes, including toluene, which optimizes the synthesis.

Another key patent focuses on synthesizing oligonucleotides on solid supports. It outlines a method wherein a solid support is combined with a filling material to create a reaction mixture. This is then placed in a reaction vessel, facilitating the efficient synthesis of oligomeric compounds. The patent also covers associated apparatuses and compositions that advance the technology of oligonucleotide synthesis.

Career Highlights

Throughout his career at Isis Pharmaceuticals, Inc., Anthony Scozzari has established himself as a leader in the innovative development of oligonucleotide synthesis methodologies. His work contributes valuable knowledge that aids in the evolution of therapies and diagnostic tools in molecular biology.

Collaborations

In his pursuits, Scozzari has collaborated with prominent professionals in his field, including Achim H. Krotz and Max N. Moore. These partnerships facilitate the exchange of ideas and advancements in technology, showcasing the collaborative spirit that drives innovation in the biotechnology sector.

Conclusion

Anthony Scozzari's contributions to oligonucleotide synthesis represent significant advancements in biotechnology. Through his innovative patents and collaborative efforts, he continues to push the boundaries of what is possible in the field, paving the way for future discoveries and applications that can benefit science and medicine alike.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…